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ABSTRACT 
Objective:  Two treatment regimens means either you have to completely/near total excise the granuloma with 
sinus clearances (extra-dural) OR don’t touch it, even minimal invasive procedure such as burr hole biopsy can 
be fatal (intra-dural). 
Introduction:  The diagnosis of intracranial fungal granuloma almost always remained a challenge for 
neurosurgeons because of their rarity, alter behavior and lack of diagnostic tools. These infections are now easily 
diagnosed because of increased awareness and understanding regarding this pathology, better diagnostic tools 
and an increase in immunocompromised/immunocompetent hosts (from any cause). Most often, the fungal 
granulomas are due to contiguous spread of the infection from the paranasal sinuses and ear. Rarely, they may be 
due to hematogenous spread from a focus in the lungs. The infection can spread from sinuses to invade the brain 
parenchyma. Once it involves the brain parenchyma then the course of the disease is fulminant. Contrast 
enhanced C.T. and MRI of brain are investigations of choice. Although morbidity and mortality from central 
nervous system (CNS) mycosis has improved over years; mortality often reaches 75 – 100% despite an intensive 
treatment strategy (surgery followed by antifungal medications). Fungal hyphae are better demonstrated on 
periodic acid Schiff and Gomorimethanamine silver stain. This study will help us to describe an improved 
management approach to such patients with intracranial fungal granuloma depending upon the extent of spread, 
whether extradural or intradural. If the granuloma is extradural, the better management is extensive surgical 
approach with sinuses clearance followed by antifungals remains the gold standard. If the granuloma is 
intradural, then surgery is abandoned/ avoided to the extent possible. 
Study Design:  Case series. 
Setting of Study:  Department of Neurosurgery, Lahore General Hospital, Lahore. 
Duration:  One year from June 2012 to July 2013. 
Materials and Methods:  Twenty patients of intracranial fungal granuloma were included in this study. 
Results:  The mean ± SD age was 33.76 ± 5.43 years. Out of total 20 patients, most of the patients 10 (50%) were 
in age group between 20 – 30 years, 6 (30%) were between 31 – 40 year, and 3 (15%) patients were between 41 – 
50 years. Only 1 (5%) patient was in age group of 51 – 60 year. There were 12 (60%) male and 8 (40%) were 
female patients. Thus the male to female ratio was 1.5:1. Out of total 20 cases, there were 18 (90%) patients had 
Aspergillosis type and only 2 (10%) patients had Mucormycosis type of fungal infection. 
Conclusions: 
 According to the two treatment regimens, whenever the granuloma is intradural/ intraparenchymal surgery is 
avoided/ abandoned but when the granuloma is extradural a more aggressive surgical approach is planned. 
 In our study most of the patients were within the age range 20 – 30 years of age with a mean age of 33.76 
years with male to female ratio of 1.5:1. 
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 There were 90% of patients of aspergillosis and only 10% patients of mucormycosis. 
Abbreviations:  MRI: Magnetic Resonance Imaging. CT: Computed Tomography. CNS) Central Nervous System. 
Key Words:  Intracranial fungal granuloma, aspergillosis, mucormycosis, immunocompromised, immuno-
competent, intradural, extradural. 
 
INTRODUCTION 
Intracranial fungal infections are seen most of the time 
among immunocompromised/immunocompetent hosts, 
of any type such as increased age, cancer chemo-
therapy, malignancies, excessive corticosteroids use, 
intravenous drug abusers and trauma/surgery, organ 
transplant, diabetes mellitus & HIV infections etc. 
Increased awareness among clinicians, better imaging 
techniques & histopathology staining has made these 
infections to diagnose as early as possible.
1-7
 
 In the brain these infections most commonly affect 
the corticomedullary junctions owing to increased vas-
cularity, spread from the nearby structures such as the 
paranasal sinuses and ears. Hematogenous spread to 
the brain from a focus in the lungs is very rare. Isola-
ted intracranial fungal granulomas without sinuses 
involvement or a focus anywhere else are extremely 
rare.
1,2,8
 
 Intracranial fungal infections can present as hea-
dache, allergic or chronic sinusitis, nasal blockage, 
vomiting, Nausea, proptosis/ptosis, detoriation of 
vision, seizures, drowsiness, cranial nerves involve-
ment and papilloedema. Contrast enhanced C.T. and 
MRI of brain (Fig. 1 & 2) are investigations of choice 
but neither of these provide definite diagnosis, they 
only detect intracranial mass or masses and involve-
ment of paranasal sinuses.
1,2,8,9
 
 Intracranial fungal granuloma once diagnosed can 
be treated conservatively and surgically. Surgical man-
agement is planned depending upon the site involved 
(extradural/intradural) with concomitant use of anti-
fungal medications. Despite such an intensive treat-
ment strategy the mortality and morbidity is extremely 
high and mortality often reaches 100%, whenever the 
granuloma is intradural and treated surgically.
1,3-7
 
 Fungal hyphae are poorly visible on routine hema-
toxylin eosin stain and are better demonstrated on peri-
odic acid Schiff and Gomorimethanamine silver stain. 
Aspergillus spores are most commonly found in areas 
where the climate is hot and dry with agricultural dust 
such as Pakistan, India, Saudi Arabia, Africa and Cali-
fornia in United States.
1
 
 This study will help us to describe an improved 
management approach to such patients with intracra-
nial fungal granuloma depending upon the extent of 
spread, whether extradural or intradural. If the granu-
loma is extradural, the better management is extensive 
surgical approach with sinuses clearance followed by 
antifungals remains the gold standard. If the granu-
loma is intradural, then surgery is abandoned/ avoided 
and only antifungal drugs are used. 
 
OBJECTIVES 
To describe the outcome of management of intra-
cranial (extradural/intradural) fungal granuloma. 
 
OPERATIONAL DEFINITIONS 
Transethmoidal/Trans-nasal Approach 
It was used to take biopsy and maximum debulking of 
the granuloma from Ethmoidal/sphenoidal air cells 
spreading to the skull base or adjacent areas. 
 
Burr Hole Biopsy 
There was suspicion of diagnosis/ when nasal sinuses 
were not involved. 
 
Craniotomy 
Used for excision of fungal granuloma from brain par-
enchyma (poor outcome). Combined approaches like 
fronto-orbital craniotomy, modified bifrontal cranio-
tomy and simple craniotomy operation. 
 There was involvement of maxillary sinuses, or-
bital area, optic nerve and anterior or middle skull base 
areas. 
 
MATERIAL AND METHODS 
Study Design 
It was a case series study. 
 
Study Universe 
This study was conducted at the Department of Neuro-
surgery, Lahore General Hospital Lahore. 
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Study Population 
20 patients of intracranial fungal granuloma were 
included in the study from June 2012 to July 2013. 
 
Inclusion Criteria 
 Gender:  Both male and female. 
 Age:  20 – 60 years. 
 All cases of intracranial fungal granuloma whether 
biopsy defined or else (high probability of fungal 
granuloma). 
 
Exclusion Criteria 
 Patients refusing from surgery. 
 Patients not fit for major surgery (Anesthesia 
unfit). 
 All other granulomas including Tuberculoma/ 
brain abscess. 
 Patients with renal (raised creatinin > 1) or hepatic 
(Billirubin > 2) dysfunction. 
 
RESULTS 
This study was carried out in the Department of Neu-
rosurgery, Lahore General Hospital, Lahore. The study 
included 20 cases of intracranial fungal granuloma. 
These patients were admitted during the period of June 
2012 to July 2013. 
 Twenty patients of intracranial fungal granuloma 
were included, shown in Table 1. Out of total 20, most 
of the patients 10 (50%) were in age group between 
20 – 30 years, 6 (30%) were between 31 – 40 year, and 
3 (15%) patients were between 41 – 50 years. Only 1 
(5%) patient was in age group between 51 – 60 years. 
The mean age was 33.76 ± 5.43 year. 
 
Table 1:  Age Distribution of Patients (n = 20). 
 
Age years No. of Patients Percentage 
20 – 30 10 50.0 
31 – 40   6 30.0 
41 – 50   3 15.0 
51 – 60   1   5.0 
 
 There were 12 (60%) male and 8 (40%) were 
female patients. Thus the male to female ratio was 
1.5:1 (Figure 3). 
Mean ± SD = 33.76 ± 5.43 
 
 
 
Fig. 1: Computed tomography scan of a patient with asper-
gillosis showing hyperdense lesion in the left tem-
poral lobe. 
 
 
 
Fig. 2: Magnetic resonance imaging with gadolinium of a 
patient with aspergillosis showing heterogeneous 
ring enhancing lesion in left temporal lobe. 
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Fig. 3:  Sex Distribution of Patients (n = 20). 
 
 Out of total 20 cases, there were 18 (90%) patients 
had Aspergillosis type and only 2 (10%) patients had 
Mucormycosis type (Figure 4). 
 Out of 20 patients, 9 (45%) patients had intradural/ 
intraparenchymal fungal granuloma, while 11 (55%) 
 
 
 
Fig. 4:  Male to female ratio = 1.5:1. 
 
Table 2:  Location, Survival & Mortality. 
 
Location  
No. of 
Patients 
(Percentage) 
Survival Mortality 
Intradural/ 
intraparenchymal 
9 (45 %) 
3 
(33.33%) 
6 
(66.67%) 
Extradural 11 (55 %) 
9 
(81.82%) 
2 
(18.18%) 
had extradural fungal granuloma (Table 2). 
 Table 2 Shows that out of the 9 (45%) patients of 
intradural/intraparenchymal fungal granuloma, 6 
(66.67%) patients expired (these patients underwent 
either minimal invasive surgery such as burr hole 
biopsy or craniotomy), 3 (33.33%) patients survived 
(these patients were diagnosed on the basis of radio-
logy and were treated conservatively), thus the morta-
lity ratio was 66.67% in case of intradural fungal gra-
nuloma. 11 (55 %) patients had extradural fungal gra-
nuloma. Out of these 11 patients 2 (18.18%) patients 
expired (possibly because of underlined concomitant 
disease) while 9 (81.82%) patients survived, thus the 
mortality ratio was 18.18% (Table 2). 
 
Table 3:  Diagnosis Criteria (n = 20). 
 
 
No. of 
Patients 
Percentage 
 Sinuses clearance 10 50.0 
 Burr hole biopsy   5 25.0 
 Radiologic impression   3 15.0 
Craniotomy   2 10.0 
 
 Patients who survived showed great response to 
inj. Amphotericin B and cap. Sporonox. The response 
was noted in terms of improvement of symptoms. 
Radi-ologically these patients showed replacement of 
granuloma with dead or necrotic tissue after six mon-
ths of treatment. 
 
DISCUSSION 
Twenty patients were included in this study. The study 
was carried out in the Department of Neurosurgery at 
Lahore General Hospital, Lahore. 
 Fungal infection of the central nervous system 
(CNS) is a life-threatening disease.
10
 Spread of the 
infection to the brain is usually via blood stream, rare-
ly there is no primary source found. After lungs and 
paranasal sinuses the third most common site of fungal 
infection is the brain. When the CNS is involved the 
course of the disease is usually fulminant mainly bec-
ause that CNS is a sanctuary site and drug penetration 
is often inadequate.
11-13
 
 In our study 50% of patients were between 20 – 30 
years of age. 6 (30%) patients were between 31 – 40 
years and 3 (15%) patients were between 41 – 50 years 
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while only 1 (5%) patient was 51 – 60 years of age. 
The mean ± SD age was 33.76 ± 5.43. The mean age 
varies, according to the inclusion criteria of various 
studies. A study done by Ramesha the mean age was 
41.2 years and age range from 23 – 66 years.7 A study 
carried out by Lin the mean age was 44.2 years with a 
range of 3 – 91 years.14 Another study conducted by 
Reed the mean age was 51 years.
15,16
 A study done by 
Nithyanandam the mean age was 48.2 years with age 
range from 14 – 69 years.17 In another study reported 
by Selvam (Indian) the mean age was 33.2 years whi-
ch is comparable with our study with a slight diffe-
rence.
6
 
 In the present study out of total 20 patients there 
were 12 patients (60%) male while 8 patients (40%) 
were female with male to female ratio of 1.5:1. In a 
study carried out by Lin distribution of gender there 
were 162 (72%) were male while 63 (28%) patients 
were female.
14
 In another study done by Nithyan-
andam there were 18 patients male and 16 patients 
were females with a male to female ratio 1.19:1 which 
is comparable with our study with a slight difference.
17
 
 In our study the mortality ranged from 66 – 100% 
in cases whenever the granuloma was intradural/ intra-
parenchymal after any surgical intervention. However, 
the mortality rate was less than 20% in cases when the 
granuloma was extradural with or without sinus invol-
vement, in such cases the mortality was always associ-
ated with underlined co morbid conditions. Such sta-
tistics are slightly comparable with many studies. In a 
study carried out by Siddiqui et al, whenever the gra-
nuloma is extradural aggressive surgical management 
is planned followed by antifungal therapy but when 
the granuloma is intradural/ intraparenchymal surgery 
is avoided to the extent possible in such cases stereo-
tactic burr hole biopsy is done only to confirm the dia-
gnosis.
11
 
 In the present study there were 18 (90%) patients 
had aspergillosis type of infection while only 2 (10%) 
patients had mucormycosis which is slightly different 
from Challa study, such a difference is due to geogra-
phic occurrence of fungus type.
1
 In comparison with a 
study carried out by Challa, out of total 86 patients 
there were 13 (15.1%) patients had intracranial fungal 
granulomas. Out of them, there were 8 (61.5%) pati-
ents with Aspergillus spp. granulomas.
9
 
 In our study 9 (45%) patients had intradural/ Intra-
parenchymal fungal granuloma while 11 (55%) had 
extradural fungal granuloma. Out of the 9 patients of 
intradural fungal granuloma 5 (25%) of the patients 
had burr hole biopsy, 1 (5%) patient had craniotomy 
and 3 (15%) patients were diagnosed based on radio-
logy. All the 6 (30%) patients of intradural fungal gra-
nuloma underwent either minimal invasive surgery or 
craniotomy expired within a week of the procedure. 
However the 3 (15%) patients of intradural fungal gra-
nuloma diagnosed based on radiology, clinical evi-
dence and involvement of sinuses survived. These pat-
ients had intradural lesion which was iso to hypoin-
tense on T2W images with contrast enhancement and 
sinuses involvement. These patients were initially trea-
ted with steroids and other measures to reduce the 
intracranial pressure, but their condition detoriate so 
steroids were stopped and antifungal therapy started 
that had lead to the clinical improvement. The role of 
steroids is controversial in many studies. 
 In our study 11 (55%) patients had extradural fun-
gal granuloma with involvement of the sinuses. Out of 
these 11 patients, 8 (40%) patients had sinus clearance 
surgery either transnasally or externally transethmoi-
dally, while one patient (5%) had craniotomy and exci-
sion of extradural aspergilloma in left temporal region, 
one patient of extradural fungal granuloma expired 
possibly because of underlined co-morbid disease. All 
the patients were treated with antifungal drugs after 
any surgical procedure/ diagnosis. These patients were 
closely monitored for their Symptomatology both 
clinically and radiologically. Their symptoms impro-
ved within days of treatment. Radiologically the affe-
cted area showed dead/ necrotic tissue after six months 
in maximum cases. 
 
CONCLUSION 
It is concluded that all over the world fungal infections 
of the central nervous system are increasingly being 
recognized. It is generally seen in immunocompromi-
sed patients but some fungi are known to affect the 
apparently immunocompetent host. Now an increased 
awareness among physicians and a high level of sus-
picion help in establishing the diagnosis. 
 According to the two treatment regimens, when-
ever the granuloma is intradural/ intraparenchymal 
surgery is avoided/abandoned but when the gra-
nuloma is extradural a more aggressive surgical 
approach is planned. 
 In our study most of the patients were within the 
age range 20 – 30 years of age with a mean of 
33.76 years while male to female ratio was 1.5:1. 
 There were 90% of patients of aspergillosis and 
only 10% patients of mucormycosis. 
 When there is a lesion that is hypo to isointense on
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T2W MRI with contrast enhancement and there is 
involvement of sinuses always suspect for fungus. 
 When there is involvement of sinuses, optic appa-
ratus, duration of symptoms is short (< 6 months) 
and the clinical condition of the patient detoriates 
with steroids then there is probability of fungus. 
 
RECOMMENDATIONS 
Whenever the granuloma is intradural/intraparenchy-
mal surgery is abandoned treat with antifungal drugs. 
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